ArriVent BioPharma Shares Fall 59% After Lung Cancer Drug Misses its Main...
Drug development has a way of compressing years of work into a single morning. That...
ArriVent BioPharma Shares Fall 59% After Lung Cancer Drug Misses its Main...
147
Drug development has a way of compressing years of work into a single morning. That morning arrived today for ArriVent...
Alector Lands $100 Million Upfront in Genentech Parkinson’s Deal
130
A $100 million payment means very different things depending on who receives it. For a global drugmaker, it is a...
Exhaustion at Work Is More Common Than Managers Assume
93
Most workplaces can measure absence. Very few can measure the person who shows up, sits down and has nothing left...
Integra LifeSciences Lowers its 2026 Outlook and Seeks a $600 Million Loan
244
A flood in Ohio and a trip to the loan market do not sound like parts of the same story,...
A Year of Acne Data Arrives as Sagimet Biosciences Heads into its...
206
Acne is often treated as a teenage nuisance, but for many people it behaves more like a chronic condition. About...
Obesity Patients Kept Losing Weight After Trading Injections for a Pill
181
For the past few years, the newest obesity medicines have come with a needle attached. Patients on Wegovy and Zepbound...
Nanexa Stock More Than Doubles After a Landmark Novo License
180
Most people taking today’s best-known obesity and diabetes drugs inject themselves once a week. That routine can last for years,...
Can Obesity Drugs Burn Fat Without Taking Muscle
197
The newest weight loss drugs have changed what doctors expect from obesity treatment. Semaglutide, sold by Novo Nordisk A/S (NYSE:...
Astrana Health Discloses Cyber Incident Built on Impersonation
181
Cybercrime in the U.S. has become a regular cost of doing business, and the figures keep rising. The FBI’s Internet...
How a Cellular Clock Could Change Cancer Treatment
179
Every cell in the human body carries a built-in limit on how many times it can divide. At the tips...
The Importance of a Strong Advisory Board
203
A clinical trial rarely fails for reasons that show up in a lab report. More often it stalls because a...
How One Insurer Deal Pushed NeurAxis Past 120 Million Covered Lives
173
Functional abdominal pain tied to irritable bowel syndrome affects a meaningful share of children and teenagers, and for years the...
A New Approach to Calming Severe Asthma Attacks
216
A clinical-stage biopharmaceutical company, Connect Biopharma Holdings Limited (NASDAQ: CNTB), shared early results from a mid-size trial testing an add-on...
Gene Therapy Trial Advances After FDA Review
205
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) has received FDA support to continue testing an experimental treatment for Danon disease, a rare...
An Antibody Designed to Read the Tumor Before Attacking It
203
Cancer that keeps coming back after chemotherapy and immunotherapy have already been tried leaves patients with painfully few paths forward,...
